During this initial phase, you may experience mild gastrointestinal symptoms such as reduced appetite, mild nausea, occasional bloating, or changes in bowel habits
People on semaglutide did appear to have some noticeable improvements in biomarkers related to Alzheimers, according to Novo Nordisk
Colafrancesco S, Barbati C, Priori R, Putro E, Giardina F, Gattamelata A, et al
Less effective than Semaglutide for most patients
All COAs are provided by Janoshik Analytics and are no older than 3 months
Therefore, one could consider a possibility that these various pathways may converge on glutathione homeostasis to promote OPC or oligodendrocyte survival under oxidative stress due to NADPH depletion